Doctor profile · Federal record
Dr. Jorge Hinojosa, MD
Dermatology Physician (CMS: Dermatology) · San Antonio, TX
- NPI 1336637370
- Accepts Medicare
- MIPS 61.3 / 100 · 2023
- 8 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1314 E Sonterra Blvd Ste 2201
San Antonio, TX 782584287
(210) 496-5792
fax (210) 496-7601
Credentials & registration
- NPI registered
- April 2018 — 8 yrs on file
- Profile last updated
- October 8, 2024
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #T3910
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1336637370. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,007
Distinct HCPCS
10
Medicare allowed
$78,925
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 212 | 185 | $87 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 144 | 56 | $6 | |
17000 |
Destruction of precancer skin growth, 1 growth | 96 | 88 | $49 | |
17110 |
Destruction of skin growth, 1-14 growths | 88 | 83 | $107 | |
96910 |
Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 87 | 17 | $112 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 87 | 78 | $120 | |
11102 |
Biopsy of related skin growth, first growth | 81 | 77 | $89 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 51 | 51 | $105 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 33 | 15 | $1 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 31 | 29 | $54 |
In context: peer comparison
Among 26 peers in San Antonio Dermatology Physician, average services per provider: 409. This provider delivers 2.5× the peer median.Open Payments
Industry payments received
All-time total
$2,993
Transactions
130
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 26 | $587.80 | |
| E.R. Squibb & Sons, L.L.C. | 18 | $367.27 | |
| Dermavant Sciences, INC. | 18 | $314.54 | |
| Lilly USA, LLC | 10 | $306.94 | |
| Genzyme Corporation | 8 | $182.87 | |
| Leo Pharma INC. | 8 | $175.23 | |
| Janssen Biotech, INC. | 5 | $155.35 | |
| Sun Pharmaceutical Industries INC. | 8 | $153.24 | |
| Ucb, INC. | 6 | $152.75 | |
| Incyte Corporation | 6 | $110.15 | |
| Novartis Pharmaceuticals Corporation | 6 | $104.84 | |
| Regeneron Healthcare Solutions, INC. | 5 | $79.70 | |
| Kerecis Limited | 2 | $66.13 | |
| Arcutis Biotherapeutics, INC. | 2 | $41.89 | |
| Pfizer INC. | 2 | $39.99 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
275
Patients
161
Total drug cost
$8,080
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 75 | 54 | $794 |
| Clobetasol Propionate | Generic | 66 | 37 | $3,580 |
| Ketoconazole | Generic | 66 | 36 | $1,226 |
| Doxycycline Hyclate | Generic | 30 | 22 | $665 |
| Metronidazole | Generic | 14 | 0 | $1,440 |
| Cephalexin | Generic | 13 | 12 | $67 |
| Clindamycin Phosphate | Generic | 11 | 0 | $309 |
Frequently asked questions
What is Dr. Jorge Hinojosa's medical specialty?
Dr. Jorge Hinojosa practices Dermatology Physician in San Antonio, TX.
Where does Dr. Jorge Hinojosa practice?
Dr. Jorge Hinojosa practices at 1314 E Sonterra Blvd Ste 2201, San Antonio, TX 782584287. Office phone: 2104965792.
What is Dr. Jorge Hinojosa's NPI?
Dr. Jorge Hinojosa's National Provider Identifier (NPI) is 1336637370, issued by NPPES.
Does Dr. Jorge Hinojosa accept Medicare assignment?
Yes. Dr. Jorge Hinojosa accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jorge Hinojosa commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.